Noreen Scherer
Hoofd Techniek/Wetenschap/O&O bij LARIMAR THERAPEUTICS, INC.
Actieve functies van Noreen Scherer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2018 | - |
| Alcobra, Inc. | Operationeel Directeur | - | - |
Loopbaan van Noreen Scherer
Eerdere bekende functies van Noreen Scherer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Noreen Scherer
| LaSalle University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Chondrial Therapeutics, Inc.
Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Health Technology |
| Alcobra, Inc. |
- Beurs
- Insiders
- Noreen Scherer
- Ervaring